Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients - Concepedia

Concepedia

Publication | Closed Access

Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients

10

Citations

33

References

2016

Year

Lingyun Zhou, Xiao‐cong Zuo, K. Chen, J.-L. Wang, Q.-J. Chen, Y.-N. Zhou, Hong Yuan, Yongmin Ma, Lin Zhu, Yuyao Peng,

Journal of Clinical Pharmacy and Therapeutics

Abstract

The CYP3A4*1G and CYP3A5*3 genetic polymorphisms are closely related to the trough concentration/dose ratios and pharmacokinetics of diltiazem and its main metabolites in Chinese adult renal transplant patients.

References

	Year	Citations

Page 1